Macrophage-Colony-Stimulating Factor Receptor Enhances Prostate Cancer Cell Growth and Aggressiveness In Vitro and In Vivo and Increases Osteopontin Expression
Résumé
Prostate cancer is a major public health concern and one of the most prevalent forms of cancer worldwide. The definition of altered signaling pathways implicated in this complex disease is thus essential. In this context, abnormal expression of the receptor of Macrophage Colony-Stimulating Factor-1 (M-CSF or CSF-1) has been described in prostate cancer cells. Yet, outcomes of this expression remain unknown. Using mouse and human prostate cancer cell lines, this study has investigated the functionality of the wild-type CSF-1 receptor in prostate tumor cells and identified molecular mechanisms underlying its ligand-induced activation. Here, we showed that upon CSF-1 binding, the receptor autophosphorylates and activates multiple signaling pathways in prostate tumor cells. Biological experiments demonstrated that the CSF-1R/CSF-1 axis conferred significant advantages in cell growth and cell invasion in vitro. Mouse xenograft experiments showed that CSF-1R expression promoted the aggressiveness of prostate tumor cells. In particular, we demonstrated that the ligandactivated CSF-1R increased the expression of spp1 transcript encoding for osteopontin, a key player in cancer development and metastasis. Therefore, this study highlights that the CSF-1 receptor is fully functional in a prostate cancer cell and may be a potential therapeutic target for the treatment of prostate cancer.
Mots clés
Mougel
A. Adriaenssens
E. Guyot
B. Tian
L. Gobert
S. Chassat
T. Persoons
P. Hannebique
D. M-CSF CSF-1 receptor prostate C2H cell line TRAMP osteopontin SPP1 transcriptome
A.
Adriaenssens
E.
Guyot
B.
Tian
L.
Gobert
S.
Chassat
T.
Persoons
P.
Hannebique
D.
M-CSF
CSF-1 receptor
prostate
C2H cell line
TRAMP
osteopontin
SPP1
transcriptome
Domaines
Cancer| Origine | Fichiers éditeurs autorisés sur une archive ouverte |
|---|